The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples.
The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider.
Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples.
“InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.”
How Foods Can Impact Mental Health
Advisers to the Food and Drug Administration are meeting to review a gene therapy technique called CRISPR to treat sickle cell disease.
October is Breast Cancer Awareness Month. Over 240,000 cases of breast cancer are diagnosed each year but today's treatments give patients a better chance at beating the disease and living a healthy life. Cheddar News spoke with Dr. Mehran Habibi, director of breast surgery with Staten Island University Hospital; Dr. Holly Marshall, division chief of breast imaging at University Hospitals Cleveland; and Dr. Neil Iyengar, breast medical oncologist with Memorial Sloan Kettering Cancer Center about the progress made in treatments.
Cheddar News checks in with your coast-to-coast weather forecast for Tuesday, Oct. 31, 2023.
Some pumpkin farmers in the West, particularly wholesalers in places like Colorado and New Mexico, are feeling the pinching effects of drought.
Breast cancer treatment advancements.
U.S. health regulators are warning consumers not to use more than two dozen varieties of over-the-counter eyedrops because of the risk of infections that could lead to blindness.
Cheddar News checks in with your coast-to-coast weather forecast for Monday, Oct. 30, 2023.
Resistance band workouts.
Clea Shearer talks breast cancer battle.
